[1]
J. Ingles Torruella, “Response to the letter to the editor of ‘Commentary on the COVID-19 mRNA vaccine reactogenicity study’”, Arch Prev Riesgos Labor, vol. 26, no. 3, pp. 217–220, Jul. 2023.